Copyright Reports & Markets. All rights reserved.

Global Deep Learning in Drug Discovery and Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Deep Learning in Drug Discovery and Diagnostics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Deep Learning in Drug Discovery and Diagnostics by Type
    • 1.3.1 Overview: Global Deep Learning in Drug Discovery and Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Deep Learning in Drug Discovery and Diagnostics Consumption Value Market Share by Type in 2023
    • 1.3.3 Drug Discovery
    • 1.3.4 Diagnostics
    • 1.3.5 Forensic Interventions
    • 1.3.6 Others
  • 1.4 Global Deep Learning in Drug Discovery and Diagnostics Market by Application
    • 1.4.1 Overview: Global Deep Learning in Drug Discovery and Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceutical Companies
    • 1.4.3 Biotechnology Companies
    • 1.4.4 Contract Research Organizations
    • 1.4.5 Healthcare IT
  • 1.5 Global Deep Learning in Drug Discovery and Diagnostics Market Size & Forecast
  • 1.6 Global Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Deep Learning in Drug Discovery and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Deep Learning in Drug Discovery and Diagnostics Market Size by Region, (2019-2030)
    • 1.6.3 North America Deep Learning in Drug Discovery and Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Deep Learning in Drug Discovery and Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Deep Learning in Drug Discovery and Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Deep Learning in Drug Discovery and Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Deep Learning in Drug Discovery and Diagnostics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Google Inc.
    • 2.1.1 Google Inc. Details
    • 2.1.2 Google Inc. Major Business
    • 2.1.3 Google Inc. Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.1.4 Google Inc. Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Google Inc. Recent Developments and Future Plans
  • 2.2 IBM Corp.
    • 2.2.1 IBM Corp. Details
    • 2.2.2 IBM Corp. Major Business
    • 2.2.3 IBM Corp. Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.2.4 IBM Corp. Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 IBM Corp. Recent Developments and Future Plans
  • 2.3 Microsoft Corporation
    • 2.3.1 Microsoft Corporation Details
    • 2.3.2 Microsoft Corporation Major Business
    • 2.3.3 Microsoft Corporation Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.3.4 Microsoft Corporation Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Microsoft Corporation Recent Developments and Future Plans
  • 2.4 Qualcomm Technologies
    • 2.4.1 Qualcomm Technologies Details
    • 2.4.2 Qualcomm Technologies Major Business
    • 2.4.3 Qualcomm Technologies Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.4.4 Qualcomm Technologies Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Qualcomm Technologies Recent Developments and Future Plans
  • 2.5 General Vision
    • 2.5.1 General Vision Details
    • 2.5.2 General Vision Major Business
    • 2.5.3 General Vision Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.5.4 General Vision Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 General Vision Recent Developments and Future Plans
  • 2.6 Insilico Medicine
    • 2.6.1 Insilico Medicine Details
    • 2.6.2 Insilico Medicine Major Business
    • 2.6.3 Insilico Medicine Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.6.4 Insilico Medicine Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Insilico Medicine Recent Developments and Future Plans
  • 2.7 NVIDIA Corporation
    • 2.7.1 NVIDIA Corporation Details
    • 2.7.2 NVIDIA Corporation Major Business
    • 2.7.3 NVIDIA Corporation Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.7.4 NVIDIA Corporation Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 NVIDIA Corporation Recent Developments and Future Plans
  • 2.8 Zebra Medical Vision
    • 2.8.1 Zebra Medical Vision Details
    • 2.8.2 Zebra Medical Vision Major Business
    • 2.8.3 Zebra Medical Vision Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.8.4 Zebra Medical Vision Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Zebra Medical Vision Recent Developments and Future Plans
  • 2.9 Enlitic
    • 2.9.1 Enlitic Details
    • 2.9.2 Enlitic Major Business
    • 2.9.3 Enlitic Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.9.4 Enlitic Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Enlitic Recent Developments and Future Plans
  • 2.10 Ginger.io
    • 2.10.1 Ginger.io Details
    • 2.10.2 Ginger.io Major Business
    • 2.10.3 Ginger.io Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.10.4 Ginger.io Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Ginger.io Recent Developments and Future Plans
  • 2.11 MedAware
    • 2.11.1 MedAware Details
    • 2.11.2 MedAware Major Business
    • 2.11.3 MedAware Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.11.4 MedAware Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 MedAware Recent Developments and Future Plans
  • 2.12 Lumiata
    • 2.12.1 Lumiata Details
    • 2.12.2 Lumiata Major Business
    • 2.12.3 Lumiata Deep Learning in Drug Discovery and Diagnostics Product and Solutions
    • 2.12.4 Lumiata Deep Learning in Drug Discovery and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Lumiata Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Deep Learning in Drug Discovery and Diagnostics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Deep Learning in Drug Discovery and Diagnostics by Company Revenue
    • 3.2.2 Top 3 Deep Learning in Drug Discovery and Diagnostics Players Market Share in 2023
    • 3.2.3 Top 6 Deep Learning in Drug Discovery and Diagnostics Players Market Share in 2023
  • 3.3 Deep Learning in Drug Discovery and Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Deep Learning in Drug Discovery and Diagnostics Market: Region Footprint
    • 3.3.2 Deep Learning in Drug Discovery and Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Deep Learning in Drug Discovery and Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Deep Learning in Drug Discovery and Diagnostics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Deep Learning in Drug Discovery and Diagnostics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Deep Learning in Drug Discovery and Diagnostics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Deep Learning in Drug Discovery and Diagnostics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Deep Learning in Drug Discovery and Diagnostics Consumption Value by Type (2019-2030)
  • 6.2 North America Deep Learning in Drug Discovery and Diagnostics Consumption Value by Application (2019-2030)
  • 6.3 North America Deep Learning in Drug Discovery and Diagnostics Market Size by Country
    • 6.3.1 North America Deep Learning in Drug Discovery and Diagnostics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Deep Learning in Drug Discovery and Diagnostics Consumption Value by Type (2019-2030)
  • 7.2 Europe Deep Learning in Drug Discovery and Diagnostics Consumption Value by Application (2019-2030)
  • 7.3 Europe Deep Learning in Drug Discovery and Diagnostics Market Size by Country
    • 7.3.1 Europe Deep Learning in Drug Discovery and Diagnostics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.3 France Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Deep Learning in Drug Discovery and Diagnostics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Deep Learning in Drug Discovery and Diagnostics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Deep Learning in Drug Discovery and Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Deep Learning in Drug Discovery and Diagnostics Consumption Value by Region (2019-2030)
    • 8.3.2 China Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.5 India Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Deep Learning in Drug Discovery and Diagnostics Consumption Value by Type (2019-2030)
  • 9.2 South America Deep Learning in Drug Discovery and Diagnostics Consumption Value by Application (2019-2030)
  • 9.3 South America Deep Learning in Drug Discovery and Diagnostics Market Size by Country
    • 9.3.1 South America Deep Learning in Drug Discovery and Diagnostics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Deep Learning in Drug Discovery and Diagnostics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Deep Learning in Drug Discovery and Diagnostics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Deep Learning in Drug Discovery and Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Deep Learning in Drug Discovery and Diagnostics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Deep Learning in Drug Discovery and Diagnostics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Deep Learning in Drug Discovery and Diagnostics Market Drivers
  • 11.2 Deep Learning in Drug Discovery and Diagnostics Market Restraints
  • 11.3 Deep Learning in Drug Discovery and Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Deep Learning in Drug Discovery and Diagnostics Industry Chain
  • 12.2 Deep Learning in Drug Discovery and Diagnostics Upstream Analysis
  • 12.3 Deep Learning in Drug Discovery and Diagnostics Midstream Analysis
  • 12.4 Deep Learning in Drug Discovery and Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Deep Learning in Drug Discovery and Diagnostics market size was valued at USD 5625.3 million in 2023 and is forecast to a readjusted size of USD 35580 million by 2030 with a CAGR of 30.1% during review period.
    Deep learning is machine learning that analyzes large volumes of labeled and unlabeled data along with multi-dimensional and complex data with non-trivial patterns.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Deep Learning in Drug Discovery and Diagnostics industry chain, the market status of Pharmaceutical Companies (Drug Discovery, Diagnostics), Biotechnology Companies (Drug Discovery, Diagnostics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Deep Learning in Drug Discovery and Diagnostics.
    Regionally, the report analyzes the Deep Learning in Drug Discovery and Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Deep Learning in Drug Discovery and Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Deep Learning in Drug Discovery and Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Deep Learning in Drug Discovery and Diagnostics industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Drug Discovery, Diagnostics).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Deep Learning in Drug Discovery and Diagnostics market.
    Regional Analysis: The report involves examining the Deep Learning in Drug Discovery and Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Deep Learning in Drug Discovery and Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Deep Learning in Drug Discovery and Diagnostics:
    Company Analysis: Report covers individual Deep Learning in Drug Discovery and Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Deep Learning in Drug Discovery and Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Companies, Biotechnology Companies).
    Technology Analysis: Report covers specific technologies relevant to Deep Learning in Drug Discovery and Diagnostics. It assesses the current state, advancements, and potential future developments in Deep Learning in Drug Discovery and Diagnostics areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Deep Learning in Drug Discovery and Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Deep Learning in Drug Discovery and Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Drug Discovery
    Diagnostics
    Forensic Interventions
    Others
    Market segment by Application
    Pharmaceutical Companies
    Biotechnology Companies
    Contract Research Organizations
    Healthcare IT
    Market segment by players, this report covers
    Google Inc.
    IBM Corp.
    Microsoft Corporation
    Qualcomm Technologies
    General Vision
    Insilico Medicine
    NVIDIA Corporation
    Zebra Medical Vision
    Enlitic
    Ginger.io
    MedAware
    Lumiata
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Deep Learning in Drug Discovery and Diagnostics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Deep Learning in Drug Discovery and Diagnostics, with revenue, gross margin and global market share of Deep Learning in Drug Discovery and Diagnostics from 2019 to 2024.
    Chapter 3, the Deep Learning in Drug Discovery and Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Deep Learning in Drug Discovery and Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Deep Learning in Drug Discovery and Diagnostics.
    Chapter 13, to describe Deep Learning in Drug Discovery and Diagnostics research findings and conclusion.

    Buy now